Tuesday 25 April 2017
The risks of Valproate medicines in female patients
The risks of Valproate medicines in female patients There is a 30% to 40% risk of developmental disorders in children born to mothers who take Valproate medicines during pregnancy. GPs should identify female patients on Valproate medicines and arrange discussions with healthcare professionals about the benefits and risks. NHS England
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment